Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate-Reference-Cited by-同舟云学术

Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate

Published:2016-04-11 Issue:8 Volume:30 Page:1708-1715
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Chaturvedi A,Araujo Cruz M M,Jyotsana N,Sharma A,Goparaju R,Schwarzer A,Görlich K,Schottmann R,Struys E A,Jansen E E,Rohde C,Müller-Tidow C,Geffers R,Göhring G,Ganser A,Thol F,Heuser M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201671.pdf

Reference38 articles.

1. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009; 361: 1058–1066.

2. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009; 360: 765–773.

3. Amary MF, Bacsi K, Maggiani F, Damato S, Halai D, Berisha F et al. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 2011; 224: 334–343.

4. Borger DR, Tanabe KK, Fan KC, Lopez HU, Fantin VR, Straley KS et al. Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist 2012; 17: 72–79.

5. Thol F, Damm F, Wagner K, Gohring G, Schlegelberger B, Hoelzer D et al. Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. Blood 2010; 116: 614–616.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RIPK3 deficiency blocks R-2-hydroxyglutarate–induced necroptosis in IDH-mutated AML cells;Science Advances;2024-04-19

2. Isocitrate Dehydrogenase Mutations in Cancer: Mechanisms of Transformation and Metabolic Liability;Cold Spring Harbor Perspectives in Medicine;2024-01-08

3. Epigenetic alterations in AML: Deregulated functions leading to new therapeutic options;International Review of Cell and Molecular Biology;2024

4. The curious case of IDH mutant acute myeloid leukaemia: biochemistry and therapeutic approaches;Biochemical Society Transactions;2023-08-01

5. Clonal evolution in leukemia: preleukemia, evolutionary models, and clinical implications;Genome Instability & Disease;2023-07-20